Oppenheimer & Co’s Enzo Biochem, Inc. ENZ Stock Holding History

Oppenheimer & Co’s Portfolio ENZ Stock Details ENZ Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q4	–	Sell	-59,502	Closed	-$189K	–	1375
2015 Q3	$189K	Hold	59,502	–	–	0.01%	1177
2015 Q2	$180K	Buy	59,502 +35,308	+146%	+$99.3K	0.01%	1328
2015 Q1	$71K	Hold	24,194	–	–	﹤0.01%	1438
2014 Q4	$107K	Buy	+24,194	New	+$115K	﹤0.01%	1321

Other funds holding ENZ

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

FLAM

First Light Asset Management Edina, Minnesota $1.12B AUM 114.45% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

GIM

Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return

LSVM

Lone Star Value Management Old Greenwich, Connecticut $52.7M AUM 30.18% 1-Year Est. Return

KIA

Kopp Investment Advisors Bloomington, Minnesota $54.4M AUM 14.33% 1-Year Est. Return

Oppenheimer & Co's ENZ Position: Q4 2015 in Review

Oppenheimer & Co sold out of Enzo Biochem, Inc. (ENZ) in Q4 2015, closing a stake of 59,502 shares — an estimated $189K sold.

Oppenheimer & Co first reported a position in ENZ in Q4 2014 and held it in 4 quarters. The position peaked at $189K in Q3 2015. 89 funds tracked by Wall St. Rank hold ENZ as of Q4 2015.

Oppenheimer & Co reported no remaining Enzo Biochem, Inc. position as of Q4 2015 after selling out during the quarter.
Oppenheimer & Co sold 59,502 Enzo Biochem, Inc. shares in Q4 2015, an estimated $189K.
Oppenheimer & Co first reported a position in Enzo Biochem, Inc. in Q4 2014 and held it in 4 quarters.
Oppenheimer & Co's Enzo Biochem, Inc. position peaked at $189K in Q3 2015.
89 funds tracked by Wall St. Rank held Enzo Biochem, Inc. as of Q4 2015.

Based on Oppenheimer & Co's 13F filing for Q4 2015, filed 3 Feb 2016.